Rogler, G (2015). Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Alimentary Pharmacology & Therapeutics, 41(8):785-786.
Statistics
Citations
Dimensions.ai Metrics
2 citations in Web of Science®
2 citations in Scopus®
2 citations in Microsoft Academic
Google Scholar™
2 citations in Scopus®
2 citations in Microsoft Academic
Google Scholar™
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Gastroenterology and Hepatology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Hepatology
Health Sciences > Gastroenterology Health Sciences > Pharmacology (medical) |
| Language: | English |
| Date: | April 2015 |
| Deposited On: | 26 Jan 2016 15:08 |
| Last Modified: | 30 Jul 2020 20:27 |
| Publisher: | Wiley-Blackwell Publishing, Inc. |
| ISSN: | 0269-2813 |
| Additional Information: | This is the peer reviewed version of the following article: [Rogler, G. (2015), Editorial: is thalidomide a good option for patients with refractory Crohn's disease?. Alimentary Pharmacology & Therapeutics, 41: 785–786. doi: 10.1111/apt.13106], which has been published in final form at [http://doi.org/10.1111/apt.13106]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-820227.html#terms). |
| OA Status: | Green |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1111/apt.13106 |
| PubMed ID: | 25781038 |
Rogler, G